HAP Trading’s Agilon Health AGL Stock Holding History

HAP Trading’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,464	Closed	-$833K	–	658
2024 Q1	$833K	Buy	+5,464	New	+$909K	0.1%	138

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HAP Trading's AGL Position: Q2 2024 in Review

HAP Trading sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 5,464 shares — an estimated $833K sold.

HAP Trading first reported a position in AGL in Q1 2024 and held it in 1 quarter. The position peaked at $833K in Q1 2024. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

HAP Trading reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
HAP Trading sold 5,464 Agilon Health shares in Q2 2024, an estimated $833K.
HAP Trading first reported a position in Agilon Health in Q1 2024 and held it in 1 quarter.
HAP Trading's Agilon Health position peaked at $833K in Q1 2024.
201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.